Contribution: Industrial Research Assistance Program – Contributions to Firms
Medo DX Pte. Ltd.
$370,000.00
MEDO.ai Thyroid - Automatic Assessment of Thyroid Ultrasound
EF 2019-20 · 2019-06-01
Résumé
Thyroid nodules are common in adults, only 7% have palpable nodules but the prevalence increases to 30% on ultrasound examination. American Thyroid Association recommends ultrasound as the first line of assessment for the stratification of risk of malignancy of thyroid nodules. Fine-needle aspiration biopsy is recommended for suspicious nodules, but these are costly and often inconclusive. An accurate image-based assessment would save time and reduce medical expense. However manual assessment of ultrasound is subjective, tedious and inconsistent especially when multiple nodules are present. This project proposes a cloud-based tool for automatic analysis and risk stratification in thyroid ultrasound which can be accessed at point-of-care.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Edmonton|Edmonton, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
761371319
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2019-06-01 | 2019-20 | $320,000.00 |
| 1 | 2019-06-01 | 2019-20 | $370,000.00 |
| 2 | 2019-06-01 | 2019-20 | $370,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 151 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 151 jours.
Agreement End Date
2021-05-31
Agreement Number
929437
Agreement Start Date
2019-06-01
Agreement Title
MEDO.ai Thyroid - Automatic Assessment of Thyroid Ultrasound
Agreement Title (French)
MEDO.ai Thyroid - Évaluation automatique des ultrasons de la thyroïde
Agreement Type
Contribution
Agreement Value
$370,000.00
Amendment Date
2020-12-16
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Thyroid nodules are common in adults, only 7% have palpable nodules but the prevalence increases to 30% on ultrasound examination. American Thyroid Association recommends ultrasound as the first line of assessment for the stratification of risk of malignancy of thyroid nodules. Fine-needle aspiration biopsy is recommended for suspicious nodules, but these are costly and often inconclusive. An accurate image-based assessment would save time and reduce medical expense. However manual assessment of ultrasound is subjective, tedious and inconsistent especially when multiple nodules are present. This project proposes a cloud-based tool for automatic analysis and risk stratification in thyroid ultrasound which can be accessed at point-of-care.
Description (French)
Les nodules thyroïdiens sont fréquents chez les adultes, seulement 7% ont des nodules palpables mais la prévalence augmente à 30% à l'échographie. L'American Thyroid Association recommande les ultrasons comme première ligne d'évaluation pour la stratification du risque de malignité des nodules thyroïdiens. La biopsie par aspiration à l'aiguille fine est recommandée pour les nodules suspects, mais elle est coûteuse et souvent peu concluante. Une évaluation précise basée sur l'imagerie permettrait de gagner du temps et de réduire les frais médicaux. Cependant, l'évaluation manuelle de tous les ultrasons est subjective, fastidieuse et incohérente, surtout lorsque plusieurs nodules sont présents. Ce projet propose un outil infonuagique pour l'analyse automatique et la stratification des risques en ultrasons thyroïdiens, qui peut être utilisé aux points de service.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
761371319
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
Medo DX Pte. Ltd.
Recipient Postal Code
T5J 1B9
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2019-2020-Q1-929437
